The healthcare sector has observed a significant advancement in diabetes management with the introduction of copyright. This innovative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to regulating blood sugar levels in individuals with type 2 diabetes. copyright works by replicating the action